Nuclear E-cadherin immunoexpression: From biology to potential applications in diagnostic pathology

Advances in Anatomic Pathology

Volumn 15, Issue 4, 2008, Pages 234-240

  Chetty, Runjan ^a,b   Serra, Stefano ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

E cadherin; Nuclear staining; Pancreas; Solid pseudopapillary tumor

Indexed keywords

ANTIBODY; BETA CATENIN; PRESENILIN 1; PROTEIN P120; UVOMORULIN; CADHERIN; DIAGNOSTIC AGENT;

CANCER SCREENING; CELL NUCLEUS; CELLULAR DISTRIBUTION; CLEAR CELL RENAL CELL CARCINOMA; COLORECTAL CANCER; CYTOPLASM; DIAGNOSTIC PROCEDURE; DISEASE COURSE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENETIC VARIABILITY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; MERKEL CELL TUMOR; MOLECULAR BIOLOGY; MOLECULE; NEUROENDOCRINE TUMOR; PANCREAS ISLET CELL TUMOR; PANCREATIC NEUROENDOCRINE TUMOR; PAPILLOMA; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOLID PSEUDOPAPILLARY TUMOR; SOLID TUMOR; STOMACH CANCER; SYNOVIAL SARCOMA; BIOPSY; IMMUNOLOGY; PANCREAS TUMOR;

ANTIBODIES; BIOPSY; CADHERINS; CELL NUCLEUS; HUMANS; PANCREATIC NEOPLASMS; PROGNOSIS;

EID: 48049102356     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0b013e31817bf566     Document Type: Review

References (38)

1. Takeichi M. The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development. 1988;102:639-655.
2. Takeichi M. Functional correlation between cell adhesive properties and some cell surface proteins. J Cell Biol. 1977;75:464-474.
3. Pignatelli M, Vessey CJ. Adhesion molecules: novel molecular tools in tumor pathology. Hum Pathol. 1994;25:849-856.
4. Nagafuchi A, Takeichi M. Cell binding function of E-cadherin is regulated by the cytoplasmic domain. Embo J. 1988;7:3679-3684.
5. Berx G, Staes K, van Hengel J, et al. Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics. 1995;26:281-289.
6. Bussemakers MJ, van Bokhoven A, Voller M, et al. The genes for the calcium-dependent cell adhesion molecules P- and E-cadherin are tandemly arranged in the human genome. Biochem Biophys Res Commun. 1994;203:1291-1294.
7. Kaupmann K, Becker-Follmann J, Scherer G, et al. The gene for the cell adhesion molecule M-cadherin maps to mouse chromosome 8 and human chromosome 16q24.1-qter and is near the E-cadherin (uvomorulin) locus in both species. Genomics. 1992;14:488-490.
8. Bussemakers MJ, Giroldi LA, van Bokhoven A, et al. Transcriptional regulation of the human E-cadherin gene in human prostate cancer cell lines: characterization of the human E-cadherin gene promoter. Biochem Biophys Res Commun. 1994;203:1284-1290.
9. Giroldi LA, Bringuier PP, de Weijert M, et al. Role of E boxes in the repression of E-cadherin expression. Biochem Biophys Res Commun. 1997;241:453-458.
10. Van Aken E, De Wever O, Correia da Rocha AS, et al. Defective E-cadherin/catenin complexes in human cancer. Virchows Arch. 2001;439:725-751.
11. Christofori G. New signals from the invasive front. Nature. 2006; 441:444-450.
12. Li LC, Chui RM, Sasaki M, et al. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res. 2000;60:873-876.
13. Wang GY, Lu CQ, Zhang RM, et al. The E-cadherin gene polymorphism 160C->A and cancer risk: a HuGE review and meta-analysis of 26 case-control studies. Am J Epidemiol. 2008; 167:7-14.
14. Xiao K, Oas RG, Chiasson CM, et al. Role of p120-catenin in cadherin trafficking. Biochim Biophys Acta. 2007;1773:8-16.
15. Yap AS, Brieher WM, Gumbiner BM. Molecular and functional analysis of cadherin-based adherens junctions. Annu Rev Cell Dev Biol. 1997;13:119-146.
16. Anastasiadis PZ, Reynolds AB. The p120 catenin family: complex roles in adhesion, signaling and cancer. J Cell Sci. 2000;113 (Pt 8): 1319-1334.
17. Oka H, Shiozaki H, Kobayashi K, et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res. 1993;53:1696-1701.
18. Gamallo C, Palacios J, Suarez A, et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol. 1993;142:987-993.
19. Becker KF, Atkinson MJ, Reich U, et al. Exon skipping in the E-cadherin gene transcript in metastatic human gastric carcinomas. Hum Mol Genet. 1993;2:803-804.
20. Becker KF, Atkinson MJ, Reich U, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 1994;54:3845-3852.
21. Nawrocki B, Polette M, Van Hengel J, et al. Cytoplasmic redistribution of E-cadherin-catenin adhesion complex is associated with down-regulated tyrosine phosphorylation of E-cadherin in human bronchopulmonary carcinomas. Am J Pathol. 1998;153: 1521-1530.
22. Deeb G, Wang J, Ramnath N, et al. Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry. Mod Pathol. 2004;17: 430-439.
23. Han AC, Soler AP, Tang CK, et al. Nuclear localization of E-cadherin expression in Merkel cell carcinoma. Arch Pathol Lab Med. 2000;124:1147-1151.
24. Serra S, Salahshor S, Fagih M, et al. Nuclear expression of E-cadherin in solid pseudopapillary tumors of the pancreas. JOP. 2007;8:296-303.
25. El-Bahrawy MA, Rowan A, Horncastle D, et al. E-cadherin/catenin complex status in solid pseudopapillary tumor of the pancreas. Am J Surg Pathol. 2008;32:1-7.
26. Tang WW, Stelter AA, French S, et al. Loss of cell-adhesion molecule complexes in solid pseudopapillary tumor of pancreas. Mod Pathol. 2007;20:509-513.
27. Kim MJ, Jang SJ, Yu E. Loss of E-cadherin and cytoplasmicnuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas. Hum Pathol. 2008;39:251-258.
28. Audard V, Cavard C, Richa H, et al. Impaired E-cadherin expression and glutamine synthetase overexpression in solid pseudopapillary neoplasm of the pancreas. Pancreas. 2008;36:80-83.
29. Dabbs DJ, Kaplai M, Chivukula M, et al. The spectrum of morphomolecular abnormalities of the E-cadherin/catenin complex in pleomorphic lobular carcinoma of the breast. Appl Immunohistochem Mol Morphol. 2007;15:260-266.
30. Izumi T, Oda Y, Hasegawa T, et al. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression. Am J Surg Pathol. 2007;31: 85-94.
31. Moon KC, Cho SY, Lee HS, et al. Distinct expression patterns of E-cadherin and beta-catenin in signet ring cell carcinoma components of primary pulmonary adenocarcinoma. Arch Pathol Lab Med. 2006; 130:1320-1325.
32. Gervais ML, Henry PC, Saravanan A, et al. Nuclear E-cadherin and VHL immunoreactivity are prognostic indicators of clear-cell renal cell carcinoma. Lab Invest. 2007;87:1252-1264.
33. Salahshor S, Naidoo R, Serra S, et al. Frequent accumulation of nuclear E-cadherin and alterations in the Wnt signaling pathway in esophageal squamous cell carcinomas. Mod Pathol. 2008;21: 271-281.
34. Chetty R, Serra S, Asa SL. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors. Am J Surg Pathol. 2008;32:413-419.
35. Chetty R, Serra S. Membrane loss and aberrant nuclear localization of E-cadherin are consistent features of solid pseudopapillary tumour of the pancreas. An immunohistochemical study using two antibodies recognizing different domains of the E-cadherin molecule. Histopathology. 2008;52:325-330.
36. Maretzky T, Reiss K, Ludwig A, et al. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc Natl Acad Sci USA. 2005;102:9182-9187.
37. van Hengel J, van Roy F. Diverse functions of p120ctn in tumors. Biochim Biophys Acta. 2007;1773:78-88.
38. Reynolds AB, Roczniak-Ferguson A. Emerging roles for p120-catenin in cell adhesion and cancer. Oncogene. 2004;23:7947-7956.